{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:56:26Z","timestamp":1783475786851,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.canlet.2020.05.013","type":"journal-article","created":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T11:30:00Z","timestamp":1590233400000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Adenovirus-mediated specific tumor tagging facilitates CAR-T therapy against antigen-mismatched solid tumors"],"prefix":"10.1016","volume":"487","author":[{"given":"Xinying","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3236-6165","authenticated-orcid":false,"given":"Md Amir","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2020.05.013_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00371","article-title":"Antigen-specific T-cell activation independently of the MHC: chimeric antigen receptor-redirected T cells","volume":"4","author":"Chmielewski","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2020.05.013_bib2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2020.05.013_bib3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ymthe.2016.10.020","article-title":"Phase 1 results of ZUMA-1: a multicenter study of KTE-C19 anti-CD19 CAR T cell therapy in refractory aggressive lymphoma","volume":"25","author":"Locke","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.canlet.2020.05.013_bib4","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2020.05.013_bib5","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1158\/1078-0432.CCR-14-1170","article-title":"Development of T Cells redirected to glypican-3 for the treatment of hepatocellular carcinoma","volume":"20","author":"Gao","year":"2014","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2020.05.013_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109427","article-title":"PSMA-specific CAR-engineered T cells eradicate disseminated prostate cancer in preclinical models","volume":"9","author":"Zuccolotto","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.canlet.2020.05.013_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010162","article-title":"Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity","volume":"6","author":"Adusumilli","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2020.05.013_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/nm.4441","article-title":"CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy","volume":"24","author":"Fry","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2020.05.013_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.2459","article-title":"Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells","volume":"31","author":"Kloss","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.canlet.2020.05.013_bib10","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.cell.2018.03.038","article-title":"Universal chimeric antigen receptors for multiplexed and logical control of T cell responses","volume":"173","author":"Cho","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2020.05.013_bib11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1158\/0008-5472.CAN-18-1834","article-title":"Use of a single CAR T cell and several bispecific adapters facilitates eradication of multiple antigenically different solid tumors","volume":"79","author":"Lee","year":"2019","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.05.013_bib12","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1368604","article-title":"mSA2 affinity-enhanced biotin-binding CAR T cells for universal tumor targeting","volume":"7","author":"Lohmueller","year":"2018","journal-title":"OncoImmunology"},{"key":"10.1016\/j.canlet.2020.05.013_bib13","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/nprot.2010.134","article-title":"An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector","volume":"5","author":"Zhou","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.canlet.2020.05.013_bib14","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/sj.cgt.7700944","article-title":"Oncolysis and suppression of tumor growth by a GFP-expressing oncolytic adenovirus controlled by an hTERT and CMV hybrid promoter","volume":"13","author":"Davis","year":"2006","journal-title":"Canc. Gene Ther."},{"key":"10.1016\/j.canlet.2020.05.013_bib15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/cgt.2008.80","article-title":"Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats","volume":"16","author":"Sonabend","year":"2009","journal-title":"Canc. Gene Ther."},{"key":"10.1016\/j.canlet.2020.05.013_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5876-10-29","article-title":"Protein L: a novel reagent for the detection of Chimeric Antigen Receptor (CAR) expression by flow cytometry","volume":"10","author":"Zheng","year":"2012","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.canlet.2020.05.013_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-018-0006-x","article-title":"Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M(+) diffuse midline gliomas","volume":"24","author":"Mount","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2020.05.013_bib18","first-page":"237","article-title":"Incorporating the survivin promoter in an infectivity enhanced CRAd-analysis of oncolysis and anti-tumor effects in vitro and in vivo","volume":"27","author":"Zhu","year":"2005","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2020.05.013_bib19","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0959-8049(97)00062-2","article-title":"A survey of telomerase activity in human cancer","volume":"33","author":"Shay","year":"1997","journal-title":"Eur. J. Canc."},{"key":"10.1016\/j.canlet.2020.05.013_bib20","article-title":"Thymosin beta10 expression driven by the human TERT promoter induces ovarian cancer-specific apoptosis through ROS production","volume":"7","author":"Kim","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.canlet.2020.05.013_bib21","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1172\/JCI83416","article-title":"Tandem CAR T cells targeting HER2 and IL13R alpha 2 mitigate tumor antigen escape","volume":"126","author":"Hegde","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2020.05.013_bib22","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/neuonc\/nox182","article-title":"Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma","volume":"20","author":"Bielamowicz","year":"2018","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2020.05.013_bib23","doi-asserted-by":"crossref","first-page":"911","DOI":"10.4049\/jimmunol.1402346","article-title":"Target antigen density governs the efficacy of anti-CD20-CD28-CD3 zeta chimeric antigen receptor-modified effector CD8(+) T cells","volume":"194","author":"Watanabe","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2020.05.013_bib24","first-page":"6359","article-title":"Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a Phase II trial","volume":"60","author":"Nemunaitis","year":"2000","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.05.013_bib25","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.cgt.7700679","article-title":"Transcriptional targeting of tumors with a novel tumor-specific survivin promoter","volume":"11","author":"Zhu","year":"2004","journal-title":"Canc. Gene Ther."},{"key":"10.1016\/j.canlet.2020.05.013_bib26","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2020.05.013_bib27","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1101\/gad.169029.111","article-title":"Immune microenvironments in solid tumors: new targets for therapy","volume":"25","author":"Shiao","year":"2011","journal-title":"Gene Dev."},{"key":"10.1016\/j.canlet.2020.05.013_bib28","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/cr.2016.142","article-title":"CRISPR-Cas9-mediated multiplex gene editing in CAR-T cells","volume":"27","author":"Liu","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2020.05.013_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.4086","article-title":"IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor","volume":"36","author":"Adachi","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.canlet.2020.05.013_bib30","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.exphem.2004.03.010","article-title":"Gene transfer into human T lymphocytes and natural killer cells by Ad5\/F35 chimeric adenoviral vectors","volume":"32","author":"Schroers","year":"2004","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.canlet.2020.05.013_bib31","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1743-6109.2006.00168.x","article-title":"Strategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal wounds","volume":"14","author":"Stoff","year":"2006","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.canlet.2020.05.013_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.09.049","article-title":"Synthetic RNA-based immunomodulatory gene circuits for cancer immunotherapy","volume":"171","author":"Nissim","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2020.05.013_bib33","first-page":"92","article-title":"Human adenovirus core protein V is targeted by the host SUMOylation machinery to limit essential viral functions","author":"Freudenberger","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2020.05.013_bib34","doi-asserted-by":"crossref","first-page":"8928","DOI":"10.1158\/0008-5472.CAN-08-1145","article-title":"Bioselection of a gain of function mutation that enhances adenovirus 5 release and improves its antitumoral potency","volume":"68","author":"Gros","year":"2008","journal-title":"Canc. Res."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383520302676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383520302676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:49:08Z","timestamp":1759592948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383520302676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":34,"alternative-id":["S0304383520302676"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2020.05.013","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenovirus-mediated specific tumor tagging facilitates CAR-T therapy against antigen-mismatched solid tumors","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2020.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}